Combined therapy with Sorafenib and FAK inhibitor TAE226 impairs hepatocellular carcinoma growth by interfering with epigenetic modifications and stemness markers
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI